Thanks, Pat. So leverage is always an area of interest, but in this quarter more so than usual. And the reason is lower profitability, which has coincided with a period of heavy investment. This has put significant pressure on leverage, which increased from 2.7 in Q2 to 3.6 in Q3. Now, of this increase, no part is related to an increase in net debt, and the increase is instead driven by two other factors of roughly equal size. To start, we see a lower underlying EBITDA gradually working its way into the rolling 12-month average used in the leverage calculation. Secondly, since we report leverage based on unadjusted EBITDA, items affecting comparability also matter. And as mentioned in the Q2 call, Q3 2024 included positive items affecting comparability, and that quarter is now replaced, if you will, by a new one with negative items affecting comparability. So this effect alone corresponded to a 0.6 increase in leverage. Now, 3.6 is high, both in relation to our targets and in relation to our financing agreements. And against that background, during Q3, we agreed with our banks on certain amendments to the terms.
And we have also, with the final steps being taken here in October, secured a one-time waiver from the bondholders through a so-called written procedure. And this change, which received strong support from the bondholders, is important because it enables us to execute the second tranche of the dividend decided upon by the AGM back in May 2025. So that payment of approximately 110 million will be made here in a few days. Looking at leverage in the longer perspective on page eight, one can see it has varied somewhat throughout the years. We've seen periods of elevated leverage followed by phases of recovery.
And it's important here to reiterate that we remain committed to our leverage target. And getting back to the 2 to 3 range is a priority. We're taking actions for that to happen.
One area of focus is working capital. And although this helped in Q3, one should not expect much support in the near term as the fourth quarter is often seasonally weak.
Another area is investment. As seen on the next page, page nine. So in Q2 and Q3, we see the investment rate declining. As we said it would. And this applies to CapEx as illustrated in the graph.
But the slowdown also applies to other investments, such as M&A, of which we've not done any, and to the ERP project, where we are now entering a less intense phase. So with those initial comments related to leverage, let's move on to profitability on page ten.
Here we saw a slight uptick from Q2, but we're still operating at levels far below last year.
On a positive note, organic growth improved from -5% in Q2 to +1% in Q3, and cash flow from operations remained healthy.
On the more challenging side, competition, as mentioned, remained ever-present, which affected gross margins as I will come back to on a later page. Competition, as mentioned, remained ever-present, affecting gross margins, which I will discuss further on a later page. Project-related activity was still intense in Q3, and this can be seen in the elevated level of items affecting comparability, which include temporary staff involved in moving goods to the new warehouses. Some of this carries over into Q4, where we have now consolidated Sørensen og Balchen's warehouse operations into the new facility outside Oslo.
And it's perhaps worth reiterating how infrequent these kinds of costs are. Our old facilities in Denmark and Norway had been operational for an average of 20 years. And we view these new investments with similar time horizons.
So it's not a very frequent event for sure. Moving to gross margin on page 11, we've already commented on competition, which was particularly noticeable in Denmark and Poland.
It's also shown that growing in a lower margin market like Poland dilutes the consolidated level, and this country effect amounts to a 1 percentage point. And this effect should be less noticeable going into Q4 because the comparables now fully reflect the acquisition of Elit Polska. Moving on and comparing adjusted EBIT with a year earlier, two areas stand out. Firstly, let's look at Sweden and Norway. It's a combination of a disappointing top line and higher fixed costs related to the automated warehouse in Norway. Secondly, Poland.
And here, it's the price pressure that has been strong, and the integration of Elit, which is not yet complete.
If we instead compare to Q2 on the next page, the picture looks a little bit different.
So what is noticeable here is, instead, an improvement in Finland.
It is, one should admit, from a low level but still worth commenting.
So let's start the business area by business area.
Review the situation in Finland on page 14.
We are, as you can see, back in positive EBIT, and organic growth of 6% helps. And even though that has come with a different mix operationally, there are some good signs.
And to exemplify, order lines per worked hour in the central warehouse are expected to be up 50% by 2025. In fact, the actions that we've taken in Finland, which include automation and cost cutting, are basically the same medicine as elsewhere. But the difference is that we've progressed further in Finland because we started earlier.
So let's move to Denmark on page 15.
Here, we witnessed an organic growth of 1%. Although measured in Swedish SEK, revenue was still down 2%.
I already mentioned competition, which has led to a lower gross margin in Q3. Looking ahead into Q4, the focus is to achieve smooth operation in the central warehouse following the move, and we are not quite there yet. Moving to Poland and the Baltics on page 16. On the positive side, we see organic growth of 9%.
However, this has come with lower margins, operationally speaking. It's worth making a distinction between Poland and the Baltics in 2025.
So in the Baltics, we have been operating in a steady state, generating decent profitability. On the other hand, it has been anything but a steady state.
We've implemented several structural changes, which are indeed good for the long term, but there's no denying that they have affected operations in 2025.
And Sweden and Norway on page 17, top line development remained muted.
EBIT margins still exceed 10%. But clearly, we are focusing on actions to improve traction in the market.
In Norway, the new central warehouse is operational, and in Q3 there was a lot of focus on getting ready for Sørensen og Balchen to move in, which happened here at the beginning of Q4. This leads us to the last business area on page 18. Sørensen og Balchen had another strong quarter, delivering an adjusted EBIT of 44 million SEK. Q3 is also the last quarter where Sørensen og Balchen operate with its own independent warehouse, and Q4 will be a transition quarter towards a model where we instead split the cost of the new central warehouse across the two business areas in Norway.
There are no new costs for the group, but for the business area, Sørensen og Balchen, they will carry a larger part of the cost, affecting comparability with earlier quarters. I would like to point out that we are also now vacating quite a few of the buildings that we have used. The period of double rent is coming to an end.
And in total, if you count the external locations. We are now out of five of the eight, including external locations. So still a little bit to go, but almost there. So with that, I'd like to hand back over to Pat.